45 results on '"Borkowetz A"'
Search Results
2. AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer
3. Urinary-exosomal transcript markers for discriminating indolent from aggressive disease of prostate cancer patients under active surveillance
4. MRI-guided active surveillance in patients with ISUP 1 prostate cancer – A multi-institutional validation of the discrimination of the PRECISE Score
5. PO-1482 Moderately hypofractionated proton therapy with implantable spacer in patients with prostate cancer
6. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
7. Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study
8. Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany
9. Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter Study
10. High diagnostic power of urinary-exosomal AMACR, ERG and PCA3 for patients with suspected prostate cancer
11. Decreasing Non–bladder-cancer Mortality After Radical Cystectomy
12. Prediction of significant prostate cancer in equivocal MRI lesions: a high-volume international multicenter study
13. Combination of urinary-exosomal AMACR, ERG and PCA3 surpasses diagnostic power of serum PSA for patients with suspected prostate cancer
14. Vascular-targeted Photodynamic Therapy in Unilateral Low-risk Prostate Cancer in Germany: 2-yr Single-centre Experience in a Real-world Setting Compared with Radical Prostatectomy
15. High diagnostic power of urinary-exosomal AMACR, ERG and PCA3 for patients with suspected prostate cancer
16. Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Large Multicenter Cohort Study
17. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer
18. Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)
19. Decreasing Non–bladder-cancer Mortality After Radical Cystectomy
20. Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2018: Increasing case numbers facilitate more high-volume centers
21. Combination of urinary-exosomal AMACR, ERG and PCA3 surpasses diagnostic power of serum PSA for patients with suspected prostate cancer
22. Treatment of postprostatectomy urinary incontinence and erectile dysfunction: Is there insufficient access to care in Germany?
23. Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)
24. Socioeconomic parameters as predictors of competing (non-bladder cancer) mortality after radical cystectomy
25. Long-term mortality in patients with positive lymph nodes at radical prostatectomy
26. Trends in surgical treatment for penile cancer in Germany from 2006 to 2015: Rising case numbers and moderate centralization
27. Long-term mortality in patients with positive lymph nodes at radical prostatectomy
28. Socioeconomic parameters as predictors of competing (non-bladder cancer) mortality after radical cystectomy
29. Trends in surgical treatment for penile cancer in Germany from 2006 to 2015: Rising case numbers and moderate centralization
30. Prediction of significant prostate cancer in patients with previously negative prostate biopsy undergoing MRI/ultrasound-fusion biopsy in combination with systematic biopsy
31. Association of NRP2 and EGFR co-expression with cancer-specific survival in prostate cancer and the influence of NRP2-depletion combined with EGFR-inhibition on cell functioning in cisplatin-sensitive and –resistant DU145 prostate cancer cell lines
32. Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survival
33. Long-term outcome and complications after ileal ureter replacement – a contemporary high-volume single-center experience
34. Prediction of significant prostate cancer in patients with previously negative prostate biopsy undergoing MRI/ultrasound-fusion biopsy in combination with systematic biopsy
35. Association of NRP2 and EGFR co-expression with cancer-specific survival in prostate cancer and the influence of NRP2-depletion combined with EGFR-inhibition on cell functioning in cisplatin-sensitive and –resistant DU145 prostate cancer cell lines
36. Long-term outcome and complications after ileal ureter replacement – a contemporary high-volume single-center experience
37. Expression of neuropilin 2 as predictor for tumour-related death in patients with prostate cancer
38. Expression of neuropilin 2 as predictor for tumour-related death in patients with prostate cancer
39. 779 Comparison of MRI/ultrasound-fusion-biopsy to systematic prostate biopsy in prediction of final histopathology in prostatectomy specimen
40. 503 Evaluation of PI-RADS classification in prediction of tumor-aggressiveness in targeted biopsy
41. 503 Evaluation of PI-RADS classification in prediction of tumor-aggressiveness in targeted biopsy
42. 209 Comparison of MRI/ultrasound-fusion-biopsy to systematic prostate biopsy in prediction of tumour aggressiveness and final histopathology
43. 209 Comparison of MRI/ultrasound-fusion-biopsy to systematic prostate biopsy in prediction of tumour aggressiveness and final histopathology
44. 90 PREPARATION FOR CLINICAL INTRODUCTION OF ADVANCED LAPAROSCOPIC PROCEDURES: LAPAROSCOPIC RENAL AUTOTRANSPLANTATION
45. 90 PREPARATION FOR CLINICAL INTRODUCTION OF ADVANCED LAPAROSCOPIC PROCEDURES: LAPAROSCOPIC RENAL AUTOTRANSPLANTATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.